• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中性粒细胞对于带有抗GD2抗体的神经母细胞瘤细胞具有细胞毒性并能抑制其生长,但在无细胞毒性时则可刺激其生长。

Neutrophils are cytotoxic and growth-inhibiting for neuroblastoma cells with an anti-GD2 antibody but, without cytotoxicity, can be growth-stimulating.

作者信息

Chen R L, Reynolds C P, Seeger R C

机构信息

Division of Hematology-Oncology, MS 57, Department of Pediatrics, Childrens Hospital Los Angeles, 4650 Sunset Boulevard, Los Angeles, CA 90054-0700, USA.

出版信息

Cancer Immunol Immunother. 2000 Feb;48(11):603-12. doi: 10.1007/s002620050008.

DOI:10.1007/s002620050008
PMID:10663607
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11037127/
Abstract

Neutrophils and mononuclear cells (MNC) can mediate antibody-dependent cellular cytotoxicity (ADCC) against cancer cells. To study cytotoxicity and growth inhibition of neuroblastoma cells by neutrophils and MNC with chimeric anti-disialoganglioside (GD2) monoclonal antibody (mAb) ch14.18, we developed digital image microscopy scanning (DIMSCAN) assays that measure fluorescence of target cells in 96-well plates after 6-18 h (cytotoxicity assay) or 7 days (growth assay). Neuroblastoma cell lines (GD2-positive: SMS-KCN, SMS-LHN, LA-N-1; GD2-negative: SK-N-SH) were preloaded with calcein acetoxymethyl ester for the cytotoxicity assay or labeled in situ after 7 days of culture with fluorescein diacetate in the growth assay. Fluorescence, as quantified by DIMSCAN, was correlated with neuroblastoma cell number in both assays (100-2000 cells/well). In the cytotoxicity test, both neutrophils and MNC effectively mediated ADCC of GD2-positive but not GD2-negative neuroblastoma cell lines. Cytotoxicity of both neutrophils and MNC increased with effector to target cell (E:T) ratio (5-50:1) and mAb ch.14.18 dose (0.1-10 microg/ml). ADCC of neutrophils, but not MNC, increased with addition of GM-CSF. Neutrophils, especially with rhGM-CSF, significantly suppressed growth of GD2-positive cell lines at a high E:T ratio (50:1) and mAb dose (10 microg/ml). Without antibody, neutrophils inhibited growth of one cell line (LA-N-1) but stimulated growth of two others (SMS-KCN, SMS-LHN). If neuroblastoma cells did not express GD2 (SK-N-SH), neutrophils stimulated growth whether or not antibody was present. Neutrophil culture supernatants increased growth of SK-N-SH, LA-N-1, and SMS-KCN cells, and MNC culture supernatants increased growth of SK-N-SH. In conclusion, neutrophils can mediate cytotoxicity and growth inhibition with a chimeric anti-GD2 antibody but also can promote tumor cell growth if antibody is not present or if GD2 is not expressed.

摘要

中性粒细胞和单核细胞(MNC)可介导针对癌细胞的抗体依赖性细胞毒性(ADCC)。为了研究嗜中性粒细胞和MNC与嵌合抗二唾液酸神经节苷脂(GD2)单克隆抗体(mAb)ch14.18对神经母细胞瘤细胞的细胞毒性和生长抑制作用,我们开发了数字图像显微镜扫描(DIMSCAN)测定法,该方法可在6 - 18小时(细胞毒性测定)或7天(生长测定)后测量96孔板中靶细胞的荧光。神经母细胞瘤细胞系(GD2阳性:SMS - KCN、SMS - LHN、LA - N - 1;GD2阴性:SK - N - SH)在细胞毒性测定中预先加载羧基荧光素乙酰甲酯,或在生长测定中培养7天后用二醋酸荧光素原位标记。通过DIMSCAN定量的荧光在两种测定中(每孔100 - 2000个细胞)均与神经母细胞瘤细胞数量相关。在细胞毒性试验中,嗜中性粒细胞和MNC均有效地介导了GD2阳性而非GD2阴性神经母细胞瘤细胞系的ADCC。嗜中性粒细胞和MNC的细胞毒性均随效应细胞与靶细胞(E:T)比例(5 - 50:1)和mAb ch.14.18剂量(0.1 - 10μg/ml)的增加而增加。加入粒细胞 -巨噬细胞集落刺激因子(GM - CSF)后,嗜中性粒细胞的ADCC增加,但MNC的ADCC未增加。嗜中性粒细胞,特别是与重组人GM - CSF(rhGM - CSF)一起,在高E:T比例(50:1)和mAb剂量(10μg/ml)下显著抑制GD2阳性细胞系的生长。在没有抗体的情况下,嗜中性粒细胞抑制一种细胞系(LA - N - 1)的生长,但刺激另外两种细胞系(SMS - KCN、SMS - LHN)的生长。如果神经母细胞瘤细胞不表达GD2(SK - N - SH),无论是否存在抗体,嗜中性粒细胞都会刺激其生长。嗜中性粒细胞培养上清液增加了SK - N - SH、LA - N - 1和SMS - KCN细胞的生长,而MNC培养上清液增加了SK - N - SH的生长。总之,嗜中性粒细胞可以用嵌合抗GD2抗体介导细胞毒性和生长抑制,但如果不存在抗体或不表达GD2,也可以促进肿瘤细胞生长。

相似文献

1
Neutrophils are cytotoxic and growth-inhibiting for neuroblastoma cells with an anti-GD2 antibody but, without cytotoxicity, can be growth-stimulating.中性粒细胞对于带有抗GD2抗体的神经母细胞瘤细胞具有细胞毒性并能抑制其生长,但在无细胞毒性时则可刺激其生长。
Cancer Immunol Immunother. 2000 Feb;48(11):603-12. doi: 10.1007/s002620050008.
2
Antidisialoganglioside/granulocyte macrophage-colony-stimulating factor fusion protein facilitates neutrophil antibody-dependent cellular cytotoxicity and depends on FcgammaRII (CD32) and Mac-1 (CD11b/CD18) for enhanced effector cell adhesion and azurophil granule exocytosis.抗唾液酸神经节苷脂/粒细胞巨噬细胞集落刺激因子融合蛋白促进中性粒细胞抗体依赖性细胞毒性作用,并且增强效应细胞黏附及嗜天青颗粒胞吐作用依赖于FcγRII(CD32)和Mac-1(CD11b/CD18)。
Blood. 2002 Jun 1;99(11):4166-73. doi: 10.1182/blood.v99.11.4166.
3
The Ch14.18-GM-CSF fusion protein is effective at mediating antibody-dependent cellular cytotoxicity and complement-dependent cytotoxicity in vitro.Ch14.18-GM-CSF融合蛋白在体外介导抗体依赖性细胞毒性和补体依赖性细胞毒性方面有效。
Clin Cancer Res. 1999 Dec;5(12):4259-63.
4
G-CSF as a suitable alternative to GM-CSF to boost dinutuximab-mediated neutrophil cytotoxicity in neuroblastoma treatment.粒细胞集落刺激因子(G-CSF)作为 GM-CSF 的替代选择,可增强神经母细胞瘤治疗中迪诺单抗介导的中性粒细胞细胞毒性。
J Immunother Cancer. 2021 May;9(5). doi: 10.1136/jitc-2020-002259.
5
Enhancement of in vitro and in vivo anti-tumor activity of anti-GD2 monoclonal antibody 220-51 against human neuroblastoma by granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor.粒细胞-巨噬细胞集落刺激因子和粒细胞集落刺激因子增强抗GD2单克隆抗体220-51对人神经母细胞瘤的体内外抗肿瘤活性
Int J Mol Med. 1998 Oct;2(4):471-5. doi: 10.3892/ijmm.2.4.471.
6
Colony-stimulating factor enhancement of myeloid effector cell cytotoxicity towards neuroectodermal tumour cells.集落刺激因子增强髓样效应细胞对神经外胚层肿瘤细胞的细胞毒性。
Br J Haematol. 1993 Apr;83(4):545-53. doi: 10.1111/j.1365-2141.1993.tb04689.x.
7
Effect of a chimeric anti-ganglioside GD2 antibody on cell-mediated lysis of human neuroblastoma cells.一种嵌合抗神经节苷脂GD2抗体对人神经母细胞瘤细胞介导的细胞溶解作用。
Cancer Res. 1991 Jan 1;51(1):144-9.
8
Anti-disialoganglioside antibody internalization by neuroblastoma cells as a mechanism of immunotherapy resistance.神经母细胞瘤细胞对抗二唾液酸神经节苷脂抗体的内化作为免疫治疗抵抗的机制。
Cancer Immunol Immunother. 2022 Jan;71(1):153-164. doi: 10.1007/s00262-021-02963-y. Epub 2021 May 27.
9
Functional bioassays for immune monitoring of high-risk neuroblastoma patients treated with ch14.18/CHO anti-GD2 antibody.用于接受ch14.18/CHO抗GD2抗体治疗的高危神经母细胞瘤患者免疫监测的功能生物测定法。
PLoS One. 2014 Sep 16;9(9):e107692. doi: 10.1371/journal.pone.0107692. eCollection 2014.
10
Phase I study of chimeric human/murine anti-ganglioside G(D2) monoclonal antibody (ch14.18) with granulocyte-macrophage colony-stimulating factor in children with neuroblastoma immediately after hematopoietic stem-cell transplantation: a Children's Cancer Group Study.造血干细胞移植后立即使用嵌合型人/鼠抗神经节苷脂G(D2)单克隆抗体(ch14.18)联合粒细胞-巨噬细胞集落刺激因子治疗神经母细胞瘤患儿的I期研究:一项儿童癌症组研究
J Clin Oncol. 2000 Dec 15;18(24):4077-85. doi: 10.1200/JCO.2000.18.24.4077.

引用本文的文献

1
Observation of neutrophil extracellular traps in the development of diabetic nephropathy using diabetic murine models.使用糖尿病小鼠模型观察糖尿病肾病发展过程中的中性粒细胞胞外陷阱
Lab Anim Res. 2024 Nov 7;40(1):38. doi: 10.1186/s42826-024-00226-2.
2
The Neuroblastoma Microenvironment, Heterogeneity and Immunotherapeutic Approaches.神经母细胞瘤的微环境、异质性及免疫治疗方法
Cancers (Basel). 2024 May 13;16(10):1863. doi: 10.3390/cancers16101863.
3
Enhancing IgA-mediated neutrophil cytotoxicity against neuroblastoma by CD47 blockade.阻断 CD47 可增强 IgA 介导的中性粒细胞对神经母细胞瘤的细胞毒性。
J Immunother Cancer. 2024 May 23;12(5):e008478. doi: 10.1136/jitc-2023-008478.
4
Targeting the myeloid microenvironment in neuroblastoma.针对神经母细胞瘤中的骨髓微环境。
J Exp Clin Cancer Res. 2023 Dec 13;42(1):337. doi: 10.1186/s13046-023-02913-9.
5
A Multi-Color Flow Cytometric Assay for Quantifying Dinutuximab Binding to Neuroblastoma Cells in Tumor, Bone Marrow, and Blood.一种用于定量评估地努图希单抗与肿瘤、骨髓和血液中神经母细胞瘤细胞结合情况的多色流式细胞术检测方法。
J Clin Med. 2023 Sep 27;12(19):6223. doi: 10.3390/jcm12196223.
6
Prediction to the prognosis of children with neuroblastoma by nomogram based on the first-diagnosed inflammatory markers.基于首次诊断时炎症标志物的列线图对神经母细胞瘤患儿预后的预测
Pediatr Surg Int. 2022 Nov 30;39(1):17. doi: 10.1007/s00383-022-05302-z.
7
A novel cuproptosis-related subtypes and gene signature associates with immunophenotype and predicts prognosis accurately in neuroblastoma.一种新型的铜死亡相关亚型和基因特征与神经母细胞瘤的免疫表型相关,并能准确预测预后。
Front Immunol. 2022 Sep 23;13:999849. doi: 10.3389/fimmu.2022.999849. eCollection 2022.
8
Pharmacogenetics in Neuroblastoma: What Can Already Be Clinically Implemented and What Is Coming Next?神经母细胞瘤的药物遗传学:已经可以临床实施的和即将到来的?
Int J Mol Sci. 2021 Sep 10;22(18):9815. doi: 10.3390/ijms22189815.
9
CD47-SIRPα Checkpoint Inhibition Enhances Neutrophil-Mediated Killing of Dinutuximab-Opsonized Neuroblastoma Cells.CD47-SIRPα 检查点抑制增强中性粒细胞介导的对二巯基丁二酸(dinutuximab)调理的神经母细胞瘤细胞的杀伤作用。
Cancers (Basel). 2021 Aug 24;13(17):4261. doi: 10.3390/cancers13174261.
10
Anti-disialoganglioside antibody internalization by neuroblastoma cells as a mechanism of immunotherapy resistance.神经母细胞瘤细胞对抗二唾液酸神经节苷脂抗体的内化作为免疫治疗抵抗的机制。
Cancer Immunol Immunother. 2022 Jan;71(1):153-164. doi: 10.1007/s00262-021-02963-y. Epub 2021 May 27.